Moderna Files to Expand the Conditional Marketing Authorization for its COVID-19 Vaccine in the European Union to Include Children Ages 6-11 Years
Go back to Moderna Files to Expand the Conditional Marketing Authorization for its COVID-19 Vaccine in the European Union to Include Children Ages 6-11 Years| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 167.50 +13.46 (8.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.04 | 52 Week High | $0.52 | |||
| Open | $161.05 | 52 Week Low | $0.08 | |||
| Day High | $170.15 | P/E | N/A | |||
| Day Low | $159.06 | EPS | $-3.80 | |||
| Volume | 7,186,544 | |||||
